Vizora日本語

Chiome BioscienceChiome Bioscience Inc.4583東証グロース医薬品FY ending Dec 2025, non-consolidated, J-GAAP

Chiome Bioscience FY ending Dec 2025 results

Chiome Bioscience brought in ¥593.3M in revenue.

It lost about ¥165 for every ¥100 of sales at the operating level.

Revenue changed -24.0% from the prior year.

What changed from last year

FY ending Dec 2024 → FY ending Dec 2025

Revenue
-24.0%¥780.8M → ¥593.3M
Gross profit
-17.9%¥432.9M → ¥355.6M
Operating income
Loss-¥1.03B → -¥979.8M
Operating cash flow
Loss-¥1B → -¥936M

Where the money goes

FY ending Dec 2024 → FY ending Dec 2025

Where ¥100 of sales goes

For every ¥100 Chiome Bioscience sells, how much goes where, and how much is kept.

FY ending Dec 2025
Cost of sales
¥40
SG&A
¥225
Operating loss
¥165
Net loss
¥166

Annual margin trends

Gross margin59.9%
FY ending Dec 2020: 51.0%51.0%FY ending Dec 2021: 59.3%59.3%FY ending Dec 2022: 55.3%55.3%FY ending Dec 2023: 58.4%58.4%FY ending Dec 2024: 55.4%55.4%FY ending Dec 2025: 59.9%59.9%FY20FY21FY22FY23FY24FY25
Operating margin-165.1%
FY ending Dec 2020: -266.9%-266.9%FY ending Dec 2021: -187.2%-187.2%FY ending Dec 2022: -199.5%-199.5%FY ending Dec 2023: -176.6%-176.6%FY ending Dec 2024: -132.0%-132.0%FY ending Dec 2025: -165.1%-165.1%FY20FY21FY22FY23FY24FY25
Net margin-165.6%
FY ending Dec 2020: -269.1%-269.1%FY ending Dec 2021: -207.6%-207.6%FY ending Dec 2022: -197.0%-197.0%FY ending Dec 2023: -178.8%-178.8%FY ending Dec 2024: -130.7%-130.7%FY ending Dec 2025: -165.6%-165.6%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2025

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第22期(2025/01/01－2025/12/31)

    ID S100XUJT2026-03-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2024/01/01－2024/12/31)

    ID S100VI6N2025-03-28Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第20期(2023/01/01－2023/12/31)

    ID S100USPT2024-11-15Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2022/01/01－2022/12/31)

    ID S100QGF62023-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第18期(令和3年1月1日－令和3年12月31日)

    ID S100NQ6T2022-03-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和2年1月1日－令和2年12月31日)

    ID S100L1372021-03-26Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image